A Pilot Study Assessing a New Eye-writing Device Allowing Cursive Writing With Smooth Pursuit Eye Movements in Subjects With ALS
The Eye On Line (EOL) device represents a novel approach to assist ALS patients in communication, addressing a significant unmet need in this patient population. The market for assistive communication devices is growing, driven by the increasing prevalence of neurodegenerative diseases. The EOL device's unique mechanism of utilizing smooth pursuit eye movements for writing could differentiate it from existing solutions, potentially capturing a niche market. Competitive analysis indicates a limited number of similar devices, suggesting a favorable position for EOL if proven effective. Diligence should focus on regulatory pathways, reimbursement strategies, and partnerships with ALS advocacy groups to enhance market penetration.
Indication: Amyotrophic Lateral Sclerosis
Modality: medical device
Target: Eye movement control for communication in ALS patients.
Sponsor: Assistance Publique - Hôpitaux de Paris
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 16, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Eye movement control for communication in ALS patients.
View original source fields
Condition raw: Amyotrophic Lateral Sclerosis
Condition normalized: Amyotrophic Lateral Sclerosis
Modality raw: medical device
Modality normalized: medical device
Target raw: Eye movement control for communication in ALS patients.
Target normalized: Eye movement control for communication in ALS patients.